Gilead Sciences Inc. Stock Falls Tuesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Gilead Sciences Inc. (GILD) sank 0.36% to $86.05 Tuesday, on what proved to be an all-aroun
UBS Adjusts Gilead Sciences Price Target to $90 From $85, Maintains Neutral Rating
UBS Adjusts Gilead Sciences Price Target to $90 From $85, Maintains Neutral Rating
Maxim Group Keeps Their Buy Rating on Gilead Sciences (GILD)
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.75
Gilead Sciences, Inc. (NASDAQ:GILD) will increase its dividend on the 30th of March to $0.75, which is 2.7% higher than last year's payment from the same period of $0.73.
Gilead Sciences (NASDAQ:GILD) Given New $112.00 Price Target at Piper Sandler
Gilead Sciences (NASDAQ:GILD – Get Rating) had its price target raised by Piper Sandler from $111.00 to $112.00 in a research note issued to investors on Friday, The Fly reports. The brokerage curren
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Hologic (HOLX) and Zimmer Biomet Holdings (ZBH)
Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Gilead Sciences Inc. (GILD) rallied 2.20% to $86.36 Monday, on what proved to be an all-aro
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Edmond DE Rothschild Holding S.A.
Edmond DE Rothschild Holding S.A. reduced its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 3.8% in the 3rd quarter, according to its most recent disclosure with the Secu
Truist Financial Sticks to Their Buy Rating for Gilead Sciences (GILD)
Robert W. Baird Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $80.00
Gilead Sciences (NASDAQ:GILD – Get Rating) had its price objective lifted by Robert W. Baird from $69.00 to $80.00 in a research note released on Friday morning, The Fly reports. Other equities analy
Loading...
No Stock Yet